Clinical studies recruiting near Naples

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Azienda Ospedaliera Universitaria Federico II · Eli Lilly and Company · NCT07218380 Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Investigational Site Number : 3800008 · Sanofi · NCT06867094 ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valve
NA · Naples Community Hospital Healthcare System · Edwards Lifesciences · NCT05172973 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · L'Azienda Ospedaliera Di Rilievo Nazionale Santobono-Pausili · Princess Maxima Center for Pediatric Oncology · NCT05327894 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Azienda Ospedaliera Universitaria Federico II · Bristol-Myers Squibb · NCT07106762 Prospective Multicenter Registry of Gender, Diversity and Inclusion (GEDI) of Women With Acute Coronary Syndrome
Phase N/A · Azienda Ospedaliera Universitaria Federico II · IRCCS San Raffaele · NCT06441942 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · University of Naples Federico II-Dipartimento di Medicina Cl · Merck Sharp & Dohme LLC · NCT06393374 REDI-CaP(Recovery of Erectile Dysfunction Induced in Prostate Cancer Patients)
Phase 2 · Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale - · National Cancer Institute, Naples · NCT07302451 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Istituto Nazionale Tumori IRCCS Fondazione Pascale · Pfizer · NCT06758401 Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt)
Phase N/A · Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. · National Cancer Institute, Naples · NCT06905262 Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML
Phase 3 · Ao Di Rilievo Nazionale Antonio Cardarelli - Napoli - Uoc Em · Gruppo Italiano Malattie EMatologiche dell'Adulto · NCT04168502 A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Phase 3 · Azienda Ospedaliera Universitaria Federico II Di Napoli · Alfasigma S.p.A. · NCT06865417 Effects of the Mediterranean Diet During Pregnancy on the Onset of Allergies in the Offspring
NA · Department of Traslational Medical Science - University of N · Federico II University · NCT05119868 Multi-omic Approach to Cancer Diagnosis: the Italian Network of Excellence for Advanced Diagnosis (INNOVA)
Phase N/A · Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. · National Cancer Institute, Naples · NCT06884878 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · AORN Ospedali dei Colli Ospedale Monaldi · Hoffmann-La Roche · NCT06793215 Lutein by Scleral Iontophoresis in AMD
Phase N/A · Federico II University · Federico II University · NCT06925893 Observational Study on Skeletal Ewing's Sarcoma
Phase N/A · Azienda Ospedaliera Santobono Pausilipon · Italian Sarcoma Group · NCT04845893 Preoperative vs Postoperative Hypofractionated Radiosurgery for Patients With Large Brain Metastases
NA · Ospedale del Mare · Istituto Clinico Humanitas · NCT05545007 Study to Evaluate Impact® as Support to Anti PD1 or Anti PD1 Based Regimen Treatment in Patients With Inoperable Locally
NA · Istituto Nazionale Tumori IRCCS - Fondazione "G. Pascale" · Fondazione Melanoma Onlus · NCT06880198 Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormon
Phase N/A · Azienda Ospedaliero-Universitaria Federico II · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT06805812 A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solut
Phase 2/Phase 3 · P.O. Ospedale del Mare /ID# 256410 · AbbVie · NCT06109272 A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pou
Phase 3 · AOU dell'Universita degli Studi della Campania Luigi Vanvite · Takeda · NCT06443502 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · AO Cardarelli · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 Use of Continuous Glucose Monitoring to Evaluate Postprandial Response to Raw Cornstarch Supplementation in Adult Glycog
Phase N/A · AOU Policlinico "Federico II" · Federico II University · NCT07645898 Endocardial Mapping With the CoreMap EP Mapping System
NA · NCH Downtown Baker Hospital · CoreMap Inc. · NCT06529978 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Azienda Ospedaliera Dei Colli · Eli Lilly and Company · NCT06890598 DynamX Bioadaptor Global Post-Market Registry: Clinical Trial of the Elixir Medical DynamX Coronary Bioadaptor System
Phase N/A · Azienda Ospedaliera Universitaria "Federico II" · Elixir Medical Corporation · NCT06074549 A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · GI Pros Research · Janssen Research & Development, LLC · NCT07499232

Look up another city

Look up another condition